Interleukin-17: Could it be a key player in COVID-19 infection severity?

NM Elsheshtawy, M Moneer… - Microbes and …, 2023 - journals.ekb.eg
Background: Exaggerated cytokines response with release of proinflammatory cytokines ie,
cytokine storm has been described with COVID-19 infection. This cytokine storm plays an …

[PDF][PDF] Evaluating serum levels of interleukin-8 and interleukin-17 in patients with COVID-19 and their correlation with disease severity

F Saebi, SMA Malaekeh, SMB Mohammadi… - 2022 - researchgate.net
Results: The average levels of these cytokines in the severe group were significantly higher
than those in the mild and control group (r= 0.48, P< 0.016); it is worth noting that patients …

The Protective Role of IL-17 and IL-22 in COVID-19 Infection

S Aksakal, S Gorgun - Iranian journal of immunology: IJI, 2024 - pubmed.ncbi.nlm.nih.gov
Background The development of a cytokine storm in Coronavirus Disease 2019 (COVID-19)
infection can make the disease fatal. We hypothesize that this excessive cytokine production …

IL-17A in COVID-19 Cases: a meta-analysis

S Fadlallah, MSS Eddin, EA Rahal - The Journal of Infection in Developing …, 2021 - jidc.org
Introduction: Numerous reviews, commentaries and opinion pieces have suggested
targeting IL-17A as part of managing Coronavirus disease 2019 (COVID-19), the notorious …

Evaluating the role of the interleukin-23/17 axis in critically ill COVID-19 patients

E Jahaj, AG Vassiliou, C Keskinidou, P Gallos… - Journal of Personalized …, 2021 - mdpi.com
Studies have hypothesized a potential role of the interleukin (IL)-23/17 axis in coronavirus
disease 2019 (COVID-19). However, to date, levels of IL-23 and 17 have not been …

[HTML][HTML] The Value of Interleukin-17A as a Prognostic Indicator in COVID-19 Patients

EF Karasahin, E Sebin, IA Sen… - Jundishapur Journal of …, 2022 - brieflands.com
Background: SARS-CoV-2 infections (COVID-19) first occurred in Wuhan, China, in
December 2019 and spread worldwide, causing significant mortality and morbidity. IL-17A …

[HTML][HTML] Gender affects IL-23 serum levels in the hospitalized COVID-19 infected patients

M Abbasifard, MK Arababadi… - American Journal of …, 2022 - ncbi.nlm.nih.gov
Cytokine storm is a main complication in the hospitalized patients, who are infected with the
novel coronavirus (COVID-19). The pro-inflammatory cytokines are the main causes of the …

IL-17A in COVID-19: a meta-analysis

S Fadlallah, MS Eddin, E Rahal - 2021 - researchsquare.com
Numerous reviews, commentaries and opinion pieces have suggested targeting IL-17A as
part of managing Coronavirus disease 2019 (COVID-19), the notorious pandemic caused by …

Predicting roles of IL-27 and IL-32 in determining the severity and outcome of COVID-19

B Zamani, M Najafizadeh… - International …, 2022 - journals.sagepub.com
Objective Immune changes play fundamental roles in the pathogenesis and severity of
coronavirus disease 2019 (COVID-19). Previous studies have revealed alterations in …

Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019

AY Majeed, NES Zulkafli, AH Ad'hiah - Beni-Suef University Journal of …, 2023 - Springer
Background This study analyzed serum concentrations of interleukin (IL)-22 and IL-33 (pro-
inflammatory and anti-inflammatory cytokines) in 90 patients with mild/moderate coronavirus …